A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according ...
The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results